<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69-ijms-21-01376">
 <label>69.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maertens</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cordonnier</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Jaksch</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Poir√©</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Uknis</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wijatyk</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Saliba</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Witzke</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Villano</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Maribavir for preemptive treatment of cytomegalovirus reactivation</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2019</year>
  <volume>381</volume>
  <fpage>1136</fpage>
  <lpage>1147</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1714656</pub-id>
  <?supplied-pmid 31532960?>
  <pub-id pub-id-type="pmid">31532960</pub-id>
 </element-citation>
</ref>
